NorthWest Biotherapeutics Inc (NWBO)

[jondoeuk]

The "DCVax Platform" is pretty old. In all this time the field has moved on. Major pharma companies know the science and history well and this is why deals have been made with those producing neoantigen based vaccines https://www.fiercebiotech.com/biotech/moderna-grabs-125m-expanded-merck-cancer-vaccine-collab https://www.fiercebiotech.com/biotech/genentech-lays-310-million-wager-biontech-s-mrna-cancer-vaccine-platform https://www.fiercebiotech.com/biotech/gritstone-bms-to-trial-immunotherapy-combos-solid-tumors

Neoantigen reactive TCRs will likely play a role too. Currently $GILD, $ZIOP and $RHHBY are working on these https://www.businesswire.com/news/home/20190104005112/en/Adaptive-Biotechnologies-Enter-Worldwide-Collaboration-License-Agreement https://www.gene.com/stories/a-new-age-for-neoantigens